Stock TRVI TREVI THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Trevi Therapeutics, Inc.

Equities

TRVI

US89532M1018

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
2.83 USD +2.17% Intraday chart for Trevi Therapeutics, Inc. +3.66% +111.19%
May. 07 Transcript : Trevi Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07 Trevi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
TREVI THERAPEUTICS, INC. Stock Trevi Therapeutics, Inc.
 195M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 21.96B -
BIONTECH SE Stock BioNTech SE
 21.87B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. TRVI Stock
  4. Charts Trevi Therapeutics, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW